This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2009.
Company Filing History:
1 out of 834,453 Years Active: 2009
Title: Michael Andrew Wynn: Innovator in Tyrosine Kinase Research
Introduction
Michael Andrew Wynn is an accomplished inventor based in Salem, MA (US). He has made significant contributions to the field of biochemistry, particularly in the study of FMS-like tyrosine kinase (FLT3). His innovative work has led to advancements in understanding protein structures and their interactions.
Latest Patents
Wynn holds a patent for the "Crystal structure of FMS-like tyrosine kinase." This invention relates to FLT3 and its binding pockets, providing a computer-encoded data storage medium with structure coordinates. The patent outlines methods for using these coordinates to solve the structures of homologous proteins and to screen for compounds that bind to the FMS-like tyrosine kinase protein. Additionally, it includes crystallizable compositions and methods for identifying inhibitors of the cytoplasmic domain of the FMS-like tyrosine kinase protein.
Career Highlights
Throughout his career, Michael Andrew Wynn has focused on the intricate details of protein structures and their implications in medical research. His work has the potential to influence drug design and therapeutic strategies for diseases related to tyrosine kinases.
Collaborations
Wynn has collaborated with notable colleagues, including James P Griffith and James Roger Black. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation.
Conclusion
Michael Andrew Wynn's contributions to the field of biochemistry, particularly through his patent on FMS-like tyrosine kinase, highlight his role as a key innovator. His work continues to pave the way for advancements in understanding protein interactions and developing new therapeutic approaches.